The Resource Antiepileptic Drugs : Pharmacology and Therapeutics, edited by M.J. Eadie, F. Vajda, (electronic resource)

Antiepileptic Drugs : Pharmacology and Therapeutics, edited by M.J. Eadie, F. Vajda, (electronic resource)

Label
Antiepileptic Drugs : Pharmacology and Therapeutics
Title
Antiepileptic Drugs
Title remainder
Pharmacology and Therapeutics
Statement of responsibility
edited by M.J. Eadie, F. Vajda
Title variation
With contributions by numerous experts
Contributor
Editor
Editor
Subject
Language
  • eng
  • eng
Summary
In 1985, volume 74 of the Springer-Verlag Handbook of Experimental Phar­ macology, under the editorship of H. -H. Frey and D. Janz, appeared. In this volume the then available data on the topic of antiepileptic drugs were col­ lated and analysed. Over the intervening years knowledge in this area has grown progressively. More new antiepileptic drugs than the total number of agents that were in common use 15 years ago have in the interval either come on to the market or are about to do so. As well, further agents are at a fairly advanced stage of development, whilst the already established drugs have by and large held their places in clinical practice. Knowledge of epileptogenesis has advanced considerably. The mechanisms of action of antiepileptic drugs at the molecular level and in various animal models of epileptic seizures and of the epileptic state are much better understood than they were previously. As well, more information is available concerning the natural history of human epilepsy, and this knowledge is important in making optimal use of the various agents that are now available. Therefore, it has seemed appropriate at this stage in the evolution of knowledge to produce a second volume dealing with Antiepileptic Drugs in the Handbook of Experimental Pharmacology series
Member of
Dewey number
615
http://bibfra.me/vocab/relation/httpidlocgovvocabularyrelatorsedt
  • D5QONUi_1q4
  • bL-e28mf_jI
Image bit depth
0
Language note
English
LC call number
RM1-950
Literary form
non fiction
Nature of contents
dictionaries
http://library.link/vocab/relatedWorkOrContributorName
  • Eadie, M.J.
  • Vajda, F.
Series statement
Handbook of Experimental Pharmacology,
Series volume
138
http://library.link/vocab/subjectName
  • Toxicology
  • Neurosciences
  • Neurology
  • Pharmacology/Toxicology
  • Neurosciences
  • Neurology
Label
Antiepileptic Drugs : Pharmacology and Therapeutics, edited by M.J. Eadie, F. Vajda, (electronic resource)
Instantiates
Publication
Note
Bibliographic Level Mode of Issuance: Monograph
Antecedent source
mixed
Bibliography note
Includes bibliographical references at the end of each chapters and index
Carrier category
online resource
Carrier category code
  • cr
Color
not applicable
Content category
text
Content type code
  • txt
Contents
1 Classification of Epileptic Seizures and the Epilepsies and Drugs of Choice for Their Treatment -- A. Introduction -- B. The International Classification of Epileptic Seizures -- C. Classification of the Epilepsies and Epileptic Syndromes -- D. Influence of Technological Advances on the Understanding of Semiology -- E. Drugs of Choice for Epileptic Seizures and the Epilepsies -- F. Conclusion -- References -- 2 Animal Models of Epilepsy and Epileptic Seizures -- A. Introduction -- B. Animal Models of Epilepsy -- C. Animal Models of Epileptic Seizures -- D. Conclusions -- References -- 3 Epileptogenesis: Electrophysiology -- A. Introduction -- B. Partial (Focal, or Lesional) Epilepsy -- C. Generalized Epilepsy: Absence Seizures -- D. Generalized Epilepsy: Convulsive Seizures -- References -- 4 Epileptogenesis: Biochemical Aspects -- A. Introduction -- B. Methods for Studying Epileptogenesis -- C. Role of Neurotransmitters in Epileptogenesis -- D. Postsynaptic Effects -- E. Neurotrophins and Neurogenesis -- F. Conclusions -- References -- 5 Cellular Actions of Antiepileptic Drugs -- A. Introduction -- B. Established Antiepileptic Drug Mechanisms of Action -- C. Newly Developed Antiepileptic Drug Mechanisms of Action -- References -- 6 The Search for New Anticonvulsants -- A. Introduction -- B. Pharmacological Strategies in the Search for New Anticonvulsants -- C. Clinical Evaluation of Preclinical Development Strategies -- D. Strategies for Future Drug Development -- E. Conclusions -- References -- 7 Measurement of Anticonvulsants and Their Metabolites in Biological Fluids -- A. Introduction -- B. Chromatographic Methods -- C. Capillary Electrophoresis and Micellar Electrokinetic Capillary Electrophoresis -- D. Stereoselective Drug Analysis -- E. Immunoassay Methods -- F. Free Drug Monitoring -- G. Quality Assurance -- References -- 8 Older Anticonvulsants Continuing in Use but with Limited Advance in Knowledge -- A. Introduction -- B. Phenobarbitone and Congeners -- C. Succinimides -- D. Sulthiame -- E. Acetazolamide -- F. Bromides -- References -- 9 Phenytoin and Congeners -- A. Phenytoin -- B. Fosphenytoin -- C. Mephenytoin -- D. Ethotoin -- E. Phenacetamide -- F. Albutoin -- References -- 10 Carbamazepine -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 11 Oxcarbazepine -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 12 Lamotrigine -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 13 Valproate -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 14 Vigabatrin -- A. Chemistry and Use -- B. Pharmacodynamics -- C. Pharmacokinetics -- D. Interactions -- E. Adverse Effects -- F. Use in Clinical Practice -- References -- 15 Benzodiazepines -- A. Introduction -- B. Pharmacodynamics of Benzodiazepines in General -- C. Benzodiazepine Adverse Effects and Their Mechanisms -- D. Diazepam -- E. Clobazam -- F. Clonazepam -- G. Lorazepam -- H. Nitrazepam -- I. Midazolam -- References -- 16 Gabapentin -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 17 Tiagabine -- A. Introduction -- B. Chemistry and Use -- C. Pharmocodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 18 Topiramate -- A. Introduction -- B. Chemistry -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- G. Clinical Use -- H. Conclusions -- References -- 19 Zonisamide -- A. Chemistry and Use -- B. Pharmacodynamics -- C. Pharmacokinetics -- D. Interactions -- E. Adverse Effects -- F. Dose and Administration -- References -- 20 Felbamate -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamic Studies -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- G. Use of Felbamate in Practice -- H. onclusions -- References -- 21 Drugs Under Clinical Trial -- A. Introduction -- B. Levetiracetam -- C Losigamone -- D. Remacemide -- E. Rufinamide -- F. Stiripentol -- G. Drugs in Early Clinical Development -- H. Conclusion -- References -- 22 Anticonvulsant Combinations and Interactions -- A. Introduction -- B. Extent of the Problem -- C. Pharmacokinetic Interactions -- D. Pharmacodynamic Interactions -- E. Interactions of the Generally Available Anticonvulsant Drugs -- F. Interactions of the Recently Licensed Anticonvulsant Drugs -- G. Conclusions -- References -- 23 The Use of Antiepileptic Drugs in Clinical Practice -- A. Introduction -- B. Changes in Antiepileptic Drug Use for Epilepsy -- C. The Decision to Prescribe Antiepileptic Drug Therapy -- D. The Choice of an Antiepileptic Drug -- E. Initiating Drug Therapy -- F. Continuing Drug Therapy -- G. Duration of Therapy -- H. Withdrawal of Therapy -- References
Dimensions
unknown
Edition
1st ed. 1999.
Extent
1 online resource (XXXVIII, 631 p.)
File format
multiple file formats
Form of item
online
Isbn
9783642600722
Level of compression
uncompressed
Media category
computer
Media type code
  • c
Other control number
10.1007/978-3-642-60072-2
Quality assurance targets
absent
Reformatting quality
access
Specific material designation
remote
System control number
  • (CKB)3400000000104887
  • (SSID)ssj0000922221
  • (PQKBManifestationID)11535268
  • (PQKBTitleCode)TC0000922221
  • (PQKBWorkID)10848640
  • (PQKB)11360790
  • (DE-He213)978-3-642-60072-2
  • (MiAaPQ)EBC3092125
  • (EXLCZ)993400000000104887
Label
Antiepileptic Drugs : Pharmacology and Therapeutics, edited by M.J. Eadie, F. Vajda, (electronic resource)
Publication
Note
Bibliographic Level Mode of Issuance: Monograph
Antecedent source
mixed
Bibliography note
Includes bibliographical references at the end of each chapters and index
Carrier category
online resource
Carrier category code
  • cr
Color
not applicable
Content category
text
Content type code
  • txt
Contents
1 Classification of Epileptic Seizures and the Epilepsies and Drugs of Choice for Their Treatment -- A. Introduction -- B. The International Classification of Epileptic Seizures -- C. Classification of the Epilepsies and Epileptic Syndromes -- D. Influence of Technological Advances on the Understanding of Semiology -- E. Drugs of Choice for Epileptic Seizures and the Epilepsies -- F. Conclusion -- References -- 2 Animal Models of Epilepsy and Epileptic Seizures -- A. Introduction -- B. Animal Models of Epilepsy -- C. Animal Models of Epileptic Seizures -- D. Conclusions -- References -- 3 Epileptogenesis: Electrophysiology -- A. Introduction -- B. Partial (Focal, or Lesional) Epilepsy -- C. Generalized Epilepsy: Absence Seizures -- D. Generalized Epilepsy: Convulsive Seizures -- References -- 4 Epileptogenesis: Biochemical Aspects -- A. Introduction -- B. Methods for Studying Epileptogenesis -- C. Role of Neurotransmitters in Epileptogenesis -- D. Postsynaptic Effects -- E. Neurotrophins and Neurogenesis -- F. Conclusions -- References -- 5 Cellular Actions of Antiepileptic Drugs -- A. Introduction -- B. Established Antiepileptic Drug Mechanisms of Action -- C. Newly Developed Antiepileptic Drug Mechanisms of Action -- References -- 6 The Search for New Anticonvulsants -- A. Introduction -- B. Pharmacological Strategies in the Search for New Anticonvulsants -- C. Clinical Evaluation of Preclinical Development Strategies -- D. Strategies for Future Drug Development -- E. Conclusions -- References -- 7 Measurement of Anticonvulsants and Their Metabolites in Biological Fluids -- A. Introduction -- B. Chromatographic Methods -- C. Capillary Electrophoresis and Micellar Electrokinetic Capillary Electrophoresis -- D. Stereoselective Drug Analysis -- E. Immunoassay Methods -- F. Free Drug Monitoring -- G. Quality Assurance -- References -- 8 Older Anticonvulsants Continuing in Use but with Limited Advance in Knowledge -- A. Introduction -- B. Phenobarbitone and Congeners -- C. Succinimides -- D. Sulthiame -- E. Acetazolamide -- F. Bromides -- References -- 9 Phenytoin and Congeners -- A. Phenytoin -- B. Fosphenytoin -- C. Mephenytoin -- D. Ethotoin -- E. Phenacetamide -- F. Albutoin -- References -- 10 Carbamazepine -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 11 Oxcarbazepine -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 12 Lamotrigine -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 13 Valproate -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 14 Vigabatrin -- A. Chemistry and Use -- B. Pharmacodynamics -- C. Pharmacokinetics -- D. Interactions -- E. Adverse Effects -- F. Use in Clinical Practice -- References -- 15 Benzodiazepines -- A. Introduction -- B. Pharmacodynamics of Benzodiazepines in General -- C. Benzodiazepine Adverse Effects and Their Mechanisms -- D. Diazepam -- E. Clobazam -- F. Clonazepam -- G. Lorazepam -- H. Nitrazepam -- I. Midazolam -- References -- 16 Gabapentin -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 17 Tiagabine -- A. Introduction -- B. Chemistry and Use -- C. Pharmocodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- References -- 18 Topiramate -- A. Introduction -- B. Chemistry -- C. Pharmacodynamics -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- G. Clinical Use -- H. Conclusions -- References -- 19 Zonisamide -- A. Chemistry and Use -- B. Pharmacodynamics -- C. Pharmacokinetics -- D. Interactions -- E. Adverse Effects -- F. Dose and Administration -- References -- 20 Felbamate -- A. Introduction -- B. Chemistry and Use -- C. Pharmacodynamic Studies -- D. Pharmacokinetics -- E. Interactions -- F. Adverse Effects -- G. Use of Felbamate in Practice -- H. onclusions -- References -- 21 Drugs Under Clinical Trial -- A. Introduction -- B. Levetiracetam -- C Losigamone -- D. Remacemide -- E. Rufinamide -- F. Stiripentol -- G. Drugs in Early Clinical Development -- H. Conclusion -- References -- 22 Anticonvulsant Combinations and Interactions -- A. Introduction -- B. Extent of the Problem -- C. Pharmacokinetic Interactions -- D. Pharmacodynamic Interactions -- E. Interactions of the Generally Available Anticonvulsant Drugs -- F. Interactions of the Recently Licensed Anticonvulsant Drugs -- G. Conclusions -- References -- 23 The Use of Antiepileptic Drugs in Clinical Practice -- A. Introduction -- B. Changes in Antiepileptic Drug Use for Epilepsy -- C. The Decision to Prescribe Antiepileptic Drug Therapy -- D. The Choice of an Antiepileptic Drug -- E. Initiating Drug Therapy -- F. Continuing Drug Therapy -- G. Duration of Therapy -- H. Withdrawal of Therapy -- References
Dimensions
unknown
Edition
1st ed. 1999.
Extent
1 online resource (XXXVIII, 631 p.)
File format
multiple file formats
Form of item
online
Isbn
9783642600722
Level of compression
uncompressed
Media category
computer
Media type code
  • c
Other control number
10.1007/978-3-642-60072-2
Quality assurance targets
absent
Reformatting quality
access
Specific material designation
remote
System control number
  • (CKB)3400000000104887
  • (SSID)ssj0000922221
  • (PQKBManifestationID)11535268
  • (PQKBTitleCode)TC0000922221
  • (PQKBWorkID)10848640
  • (PQKB)11360790
  • (DE-He213)978-3-642-60072-2
  • (MiAaPQ)EBC3092125
  • (EXLCZ)993400000000104887

Library Locations

  • Architecture LibraryBorrow it
    Gould Hall 830 Van Vleet Oval Rm. 105, Norman, OK, 73019, US
    35.205706 -97.445050
  • Bizzell Memorial LibraryBorrow it
    401 W. Brooks St., Norman, OK, 73019, US
    35.207487 -97.447906
  • Boorstin CollectionBorrow it
    401 W. Brooks St., Norman, OK, 73019, US
    35.207487 -97.447906
  • Chinese Literature Translation ArchiveBorrow it
    401 W. Brooks St., RM 414, Norman, OK, 73019, US
    35.207487 -97.447906
  • Engineering LibraryBorrow it
    Felgar Hall 865 Asp Avenue, Rm. 222, Norman, OK, 73019, US
    35.205706 -97.445050
  • Fine Arts LibraryBorrow it
    Catlett Music Center 500 West Boyd Street, Rm. 20, Norman, OK, 73019, US
    35.210371 -97.448244
  • Harry W. Bass Business History CollectionBorrow it
    401 W. Brooks St., Rm. 521NW, Norman, OK, 73019, US
    35.207487 -97.447906
  • History of Science CollectionsBorrow it
    401 W. Brooks St., Rm. 521NW, Norman, OK, 73019, US
    35.207487 -97.447906
  • John and Mary Nichols Rare Books and Special CollectionsBorrow it
    401 W. Brooks St., Rm. 509NW, Norman, OK, 73019, US
    35.207487 -97.447906
  • Library Service CenterBorrow it
    2601 Technology Place, Norman, OK, 73019, US
    35.185561 -97.398361
  • Price College Digital LibraryBorrow it
    Adams Hall 102 307 West Brooks St., Norman, OK, 73019, US
    35.210371 -97.448244
  • Western History CollectionsBorrow it
    Monnet Hall 630 Parrington Oval, Rm. 300, Norman, OK, 73019, US
    35.209584 -97.445414
Processing Feedback ...